The US Food and Drug Administration (FDA) “will not delay, but will not cut corners” in approving a […]
UK-headquartered company will characterise autoantibody profiles of clinical trial patients
Phase III trial programme will evaluate nebulised ensifentrine in moderate-to-severe COPD
UCB is seeking approval for treatment in moderate-to-severe plaque psoriasis
App will automatically alert users when they come into close contact with someone with the virus
Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst aliu Thu, 09/24/2020 – 10:15
Gilead inks $97M charity kickbacks settlement with feds, but argues it did no wrong esagonowsky Thu, 09/24/2020 – […]
J&J’s next-gen Darzalex sparks drug delivery royalties battle fkansteiner Thu, 09/24/2020 – 09:40
Pfizer leans into gene therapy manufacturing with ‘build-buy-partner’ strategy kblankenship Thu, 09/24/2020 – 09:38
Regeneron and Sanofi won’t dethrone Merck in lung cancer despite strong Libtayo data: analysts arlene.weintraub Thu, 09/24/2020 – […]